|
|
 
 |
| DENTAL SCIENCE - REVIEW ARTICLE |
|
| Year : 2012 | Volume
: 4
| Issue : 6 | Page : 307-309 |
|
|
Applications of immunohistochemistry
Jeyapradha Duraiyan1, Rajeshwar Govindarajan2, Karunakaran Kaliyappan2, Murugesan Palanisamy3
1 Department of Oral and Maxillofacial Pathology, Thai Moogambigai Dental College & Hospital, Chennai, India
2 Department of Oral and Maxillofacial Pathology, J K K Nataraja Dental College & Hospital, Komarapalayam, Namakkal, Tamil Nadu, India
3 Department of Bio Chemistry, J K K Nataraja Dental College & Hospital, Komarapalayam, Namakkal, Tamil Nadu, India
| Date of Submission | 01-Dec-2011 |
| Date of Decision | 02-Jan-2012 |
| Date of Acceptance | 26-Jan-2012 |
| Date of Web Publication | 28-Aug-2012 |
Correspondence Address:
Karunakaran Kaliyappan
Department of Oral and Maxillofacial Pathology, J K K Nataraja Dental College & Hospital, Komarapalayam, Namakkal, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0975-7406.100281
 Abstract | | |
Immunohistochemistry (IHC) is an important application of monoclonal as well as polyclonal antibodies to determine the tissue distribution of an antigen of interest in health and disease. IHC is widely used for diagnosis of cancers; specific tumor antigens are expressed de novo or up-regulated in certain cancers. This article deals with the various applications of IHC in diagnosis of diseases, with IHC playing an important role in diagnostic and research laboratories. Keywords: Antibody, antigen, disease, immunohistochemistry
How to cite this article:
Duraiyan J, Govindarajan R, Kaliyappan K, Palanisamy M. Applications of immunohistochemistry. J Pharm Bioall Sci 2012;4, Suppl S2:307-9 |
Immunohistochemistry (IHC), the utilization of monoclonal and polyclonal antibodies for the detection of specific antigens in tissue sections, is an extraordinarily powerful tool in the armamentarium of the diagnostic surgical pathologist. IHC is an important application of monoclonal as well as polyclonal antibodies to determine the tissue distribution of an antigen of interest in health and disease. It is widely used for diagnosis of cancers because specific tumor antigens are expressed de novo or up-regulated in certain cancers. IHC plays an important role in pathology, particularly in the subspecialties of oncologic pathology, neuropathology, and hematopathology. Utilization studies are rare, [1] but several authors have reviewed the diagnostic utility of IHC in surgical pathology. [2],[3],[4] In autopsy pathology while basic histologic examination of tissue is considered a useful and necessary component IHC may provide a greater insight. [5],[6]
IHC requires the availability of biopsies; these are processed into sections with a microtome and then the sections are incubated with an appropriate antibody. The site of antibody binding is visualized under an ordinary or fluorescent microscope by a marker such as fluorescent dye, enzyme, radioactive element, or colloidal gold, which is directly linked to the primary antibody or to an appropriate secondary antibody.
| The Principle of IHC | |  |
The principle of IHC has existed since the 1930s, but it was not until 1941 that the first IHC study was reported. [7] Coons and his colleagues used Fluorescein isothiocyanate (FITC)-labeled antibodies with a fluorescent dye to localize pneumococcal antigens in infected tissues. With the expansion and development of IHC technique, enzyme labels have been introduced, such as peroxidase [8],[9] and alkaline phosphatase. [10] Colloidal gold [11] label has also been discovered and used to identify immunohistochemical reactions at both light and electron microscopy levels. Other labels include radioactive elements, and the immunoreaction can be visualized by autoradiography.The aim of IHC is to perform most IHC staining by causing least damage on the cell or tissue, and by using least amount of antibody, it finds a way in the tumor typing and tumor markers.
| Applications | | |
Since IHC involves specific antigen-antibody reactions, it has apparent advantage over traditionally used special enzyme staining techniques that identify only a limited number of proteins, enzymes, and tissue structures. Therefore, IHC has become a crucial technique and is widely used in many medical research laboratories as well as clinical diagnostics. [12]
| Prognostic Markers in Cancer | | |
To predict the prognosis of tumors by identification of enzymes, tumor-specific antigens, oncogenes, tumor suppressor genes, and tumor cell proliferation markers. Analysis of tumors by these methods is a significant improvement over the conventional prognostic considerations by clinical staging and histologic grading. IHC is used for disease diagnosis, drug development, and biological research. Using specific tumor markers, physicians use IHC to diagnose a cancer as benign or malignant, determine the stage and grade of a tumor, and identify the cell type and origin of a metastasis to find the site of the primary tumor. IHC is also used in drug development to test drug efficacy by detecting either the activity or the up- or down-regulation of disease targets. [13]
| Tumors of Uncertain Histogenesis | | |
IHC methods have brought about a revolution in approach to diagnosis of tumors of uncertain origin, primary as well as metastatic from unknown primary tumor. A panel of antibodies is chosen to resolve such diagnostic problem cases. The selection of antibodies being made is based on clinical history, morphological features, and results of other relevant investigations. Immunohistochemical stains for intermediate filaments are expressed by tumor cells (keratin, desmin, vimentin, neurofilaments, and glial fibrillary acidic proteins). [13]
| Prediction of Response to Therapy | | |
IHC is widely used to predict therapeutic response in two important tumors, i.e. carcinoma of breast and prostate. Both these tumors are under the growth regulation of the hormones estrogen and androgen, respectively. The specific receptors for these growth regulating hormones are located on respective tumor cells. Tumors expressing high level of receptor positivity would respond favorably to removal of the endogenous source of such hormones or hormonal therapy is administered to lower their levels - estrogen therapy in prostate cancer and androgen therapy in breast cancer. [13]
| Infections | | |
Immunohistochemical methods are also being applied to confirm infectious agent in tissues by use of specific antibodies against microbial DNA or RNA, e.g. in Cytomegalo virus, Hepatitis B virus, Hepatitis C virus, etc. The application is used routinely in validation of disease targets as it allows visualizing expression of the target in the affected tissue during the disease process. The concept was introduced as early as the 1940s when fluorescein dye (visible under ultraviolet light) was tagged to antibodies directed against pneumococci for identification of this organism with specific anti-serum. [7] This method, often abbreviated IFA for "immunofluorescence assay", has been widely used for the detection of specific pathogens, viral as well as bacterial and protozoal, in "fresh"/unfixed tissues in both human and veterinary medicine.
Another important advantage of IHC is that it can also be used to detect organisms in cytological preparations such as fluids, sputum samples, and material obtained from fine needle aspiration procedures. This can be very helpful in certain situations such as detection of pneumocystis from the sputum of an immunocompromised patient who needs rapid and precise confirmation of infection in order to begin immediate and appropriate therapy.
| In Genetics | | |
IHC can also be used to determine the function of specific gene products in fundamental biological processes such as development and apoptosis. Using a custom made monoclonal antibody against p53 homologue of the pro-apoptotic pathways of p53 was identified.
| Neurodegenerative Disorders | | |
Degenerative disorders of the nervous system include a wide range of diseases characterized by the dysfunction and death of specific, selectively vulnerable populations of nerve cells. It has played an increasingly important role in the subclassification of neurodegenerative disorders and the development of consensus criteria for their diagnosis.
| Brain Trauma | | |
In the last few years, immunohistochemical staining for beta amyloid precursor protein has been validated as a method to detect axonal injury within as little as 2-3 h of head injury. [14] Immunohistochemical detection of axonal injury can be useful in establishing timing of a traumatic insult in medico-legal settings.
| IHC in Muscle Diseases | | |
Specific diagnosis of muscular dystrophy is important because of the genetic counseling implications of inherited disease and accurate prognostication. In recent years, abnormalities in several muscle proteins have been identified in muscular dystrophies. Such abnormalities involve proteins located in the sarcolemma, extracellular matrix, cytosol, nucleus, and other sites within muscle fibers. [15] Skeletal muscle biopsy can play a main role in differentiating vascular dystrophy from non-dystrophic disorders and IHC can assist in establishing a specific diagnosis of the dystrophies for which specific protein abnormalities are known.
| Research Application | | |
Much of the current research into the causes of neurodegenerative diseases is directed at identifying the factors that result in the formation of paired helical filaments, the deposition of beta amyloid, cytoplasmic accumulations of alpha synuclein, etc. Consequently, studies to localize and quantify the abnormal proteins that constitute reasons of neurodegenerative diseases are of central importance. IHC using antibodies to beta amyloid, alpha synuclein, ubiquitin, huntingtin, polyglutamine, and others has become a routine tool for a sensitive detection and quantification of these abnormal proteins in both human tissues and in experimental animals that are used to model some of the features of these diseases. IHC is an important tool in diagnostic and research laboratories.
| References | | |
| 1. | Ajura AJ, Sumairi I, Lau SH. The use of immunohistochemistry in an oralpathology laboratory, Malays. J Pathol 2007;29:101-5. 
|
| 2. | Edgar MA, Rosenblum MK. The differential diagnosis of central nervous system tumors: A critical examination of some recent immunohistochemical applications. Arch Pathol Lab Med 2008;132:500-9.
|
| 3. | Garcia CF, Swerdlow SH. Best practices in contemporary diagnostic immunohistochemistry: Panel approach to hematolymphoid proliferations. Arch Pathol Lab Med 2009;133:756-65.
|
| 4. | Leong AS, Wright J. The contribution of immunohistochemical staining in tumor diagnosis. Histopathology 1987;11:1295-305.
|
| 5. | Bernardi FD, Saldiva PH, Mauad T. Histological examination has a majorimpact on macroscopic necropsy diagnoses. J Clin Pathol 2005;58:1261-4.
|
| 6. | Roulson J, Benbow EW, Hasleton PS. Discrepancies between clinical andautopsy diagnosis and the value of post mortem histology; A meta-analysisand review. Histopathology 2005;47:551-9.
|
| 7. | Coons AH, Creech HJ, Jones RN. Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol 1941;47:200-2.
|
| 8. | Coons AH, Kalpan MH. Localization antigens in tissue cells. Improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med 1950;91:1-13.
|
| 9. | Nakane PK, Pierce GB. Enzyme labeled anti-bodies: Preparation and application for the localization of antigens. J Histochem Cytochem 1966;14:929-31.
|
| 10. | Mason DY, Sammons R. alkaline phosphatase and peroxidase for double immunoenzymatic labeling of cellular constituents. J Clin Pathol 1978;31:454-60.
|
| 11. | Faulk WP, Taylor GM. An immunocolloid method for the electron microscope. Immunochemistry 1971;8:1081-83.
|
| 12. | Rajendran, Shafer's textbook of oral pathology, 6 th edition, Elsevier, India, 2009, p.932.
|
| 13. | Harsh Mohan. Essential pathology for dental students, 3 rd edition, Jaypee brother's medical publishers, New Delhi, 2005, p.14.
|
| 14. | Sherriff FE, Bridges LR, Sivaloganathan S. Early detection of axonal injury after human head trauma using immunohistochemistry for beta-amyloid precursor protein. Actaneuropathologica 1994;87:55-62.
|
| 15. | Vainzof M, Zata M. Protein defects in neuromuscular diseases. Braz J Med Biol Res 2003;36:543-55.
|
| This article has been cited by | | 1 |
Artificial intelligence to identify genetic alterations in conventional histopathology |
|
| Didem Cifci, Sebastian Foersch, Jakob Nikolas Kather | | The Journal of Pathology. 2022; | | [Pubmed] | [DOI] | | | 2 |
Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation |
|
| Huy Hoang Dang, Hoang Dang Khoa Ta, Truc T. T. Nguyen, Gangga Anuraga, Chih-Yang Wang, Kuen-Haur Lee, Nguyen Quoc Khanh Le | | Functional & Integrative Genomics. 2022; | | [Pubmed] | [DOI] | | | 3 |
Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update |
|
| Anthony McGuigan, James Whitworth, Avgi Andreou, Timothy Hearn, J. C. Ambrose, P. Arumugam, R. Bevers, M. Bleda, F. Boardman-Pretty, C. R. Boustred, H. Brittain, M. J. Caulfield, G. C. Chan, T. Fowler, A. Giess, A. Hamblin, S. Henderson, T. J. P. Hubbard, R. Jackson, L. J. Jones, D. Kasperaviciute, M. Kayikci, A. Kousathanas, L. Lahnstein, S. E. A. Leigh, I. U. S. Leong, F. J. Lopez, F. Maleady-Crowe, M. McEntagart, F. Minneci, L. Moutsianas, M. Mueller, N. Murugaesu, A. C. Need, P. O‘Donovan, C. A. Odhams, C. Patch, D. Perez-Gil, M. B. Pereira, J. Pullinger, T. Rahim, A. Rendon, T. Rogers, K. Savage, K. Sawant, R. H. Scott, A. Siddiq, A. Sieghart, S. C. Smith, A. Sosinsky, A. Stuckey, M. Tanguy, A. L. Taylor Tavares, E. R. A. Thomas, S. R. Thompson, A. Tucci, M. J. Welland, E. Williams, K. Witkowska, S. M. Wood, Marc Tischkowitz, Eamonn R. Maher | | European Journal of Human Genetics. 2022; | | [Pubmed] | [DOI] | | | 4 |
The Spectrum of Spitz Melanocytic Lesions: From Morphologic Diagnosis to Molecular Classification |
|
| Tiffany W. Cheng, Madeline C. Ahern, Alessio Giubellino | | Frontiers in Oncology. 2022; 12 | | [Pubmed] | [DOI] | | | 5 |
Effects of Sparganii Rhizoma on Osteoclast Formation and Osteoblast Differentiation and on an OVX-Induced Bone Loss Model |
|
| Sungyub Lee, Minsun Kim, Sooyeon Hong, Eom Ji Kim, Jae-Hyun Kim, Youngjoo Sohn, Hyuk-Sang Jung | | Frontiers in Pharmacology. 2022; 12 | | [Pubmed] | [DOI] | | | 6 |
Simultaneous Visualization of MiRNA-221 and Caspase-3 in Cancer Cells for Investigating the Feasibility of MiRNA-Targeted Therapy with a Dual-Color Fluorescent Nanosensor |
|
| Mingyao Ren, Zhe Chen, Chuandong Ge, Wei Hu, Nianxing Wang, Limin Yang, Mingming Luan, Jing Xu | | Biosensors. 2022; 12(7): 444 | | [Pubmed] | [DOI] | | | 7 |
Techniques for Profiling the Cellular Immune Response and Their Implications for Interventional Oncology |
|
| Tushar Garg, Clifford R. Weiss, Rahul A. Sheth | | Cancers. 2022; 14(15): 3628 | | [Pubmed] | [DOI] | | | 8 |
Diagnostic Utility of Cytokeratin 17 Expression in Oral Squamous Cell Carcinoma: A Review |
|
| Ankita Gyanchandani, Samarth Shukla, Sunita Vagha, Sourya Acharaya , Ravindra P Kadu | | Cureus. 2022; | | [Pubmed] | [DOI] | | | 9 |
ImmuCellDB: An Indicative Database of Immune Cell Composition From Different Tissues and Disease Conditions in Mouse and Human |
|
| Ziyi Chen, Han Na, Aiping Wu | | Frontiers in Immunology. 2021; 12 | | [Pubmed] | [DOI] | | | 10 |
Detection of Human Cytomegalovirus Proteins in Paraffin-Embedded Breast Cancer Tissue Specimens—A Novel, Automated Immunohistochemical Staining Protocol |
|
| Joel Touma, Yan Liu, Afsar Rahbar, Mattia Russel Pantalone, Nerea Martin Almazan, Katja Vetvik, Cecilia Söderberg-Nauclér, Jürgen Geisler, Torill Sauer | | Microorganisms. 2021; 9(5): 1059 | | [Pubmed] | [DOI] | | | 11 |
Changing Trends in Dermatopathology Case Complexity: A 9-Year Academic Center Experience |
|
| Anna M. Stagner, Steven R. Tahan, Rosalynn M. Nazarian | | Archives of Pathology & Laboratory Medicine. 2021; 145(9): 1144 | | [Pubmed] | [DOI] | | | 12 |
Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe |
|
| Tatjana Huebner, Catharina Scholl, Michael Steffens | | Diagnostics. 2021; 11(7): 1169 | | [Pubmed] | [DOI] | | | 13 |
Clinical Significance of Peritoneal Fluid Examination for Free Cancer Cells in Patients Qualified for Surgery for Gastric Cancer |
|
| Slawomir Ciesla, Radoslaw Lisiecki, Agnieszka Lawnicka, Bartosz Kudlinski, Paulina Ostrowska, Alberto Davì, Massimiliano Veroux, Dawid Murawa | | Frontiers in Surgery. 2021; 8 | | [Pubmed] | [DOI] | | | 14 |
Importance of immunohistochemical staining in differential diagnosis of extramammary Paget and Bowen’s diseases located in female anogenital region – a case report |
|
| Martyna Pawlak, Konrad Reszka, Lukasz Moskal, Marcin Stepien | | Journal of Obstetrics and Gynaecology. 2021; : 1 | | [Pubmed] | [DOI] | | | 15 |
Progress and challenge for computational quantification of tissue immune cells |
|
| Ziyi Chen, Aiping Wu | | Briefings in Bioinformatics. 2021; 22(5) | | [Pubmed] | [DOI] | | | 16 |
A call to action: molecular pathology in Brazil |
|
| Isabela Werneck da Cunha, Renata de Almeida Coudry, Mariana Petaccia de Macedo, Emilio Augusto Campos Pereira de Assis, Stephen Stefani, Fernando Augusto Soares | | Surgical and Experimental Pathology. 2021; 4(1) | | [Pubmed] | [DOI] | | | 17 |
Diagnostic Utility of Ki-67 for Histopathological Typing of Conventional Ameloblastoma, Proliferative Ameloblastoma and Ameloblastic Carcinoma – A Retrospective Study |
|
| Mithra S., Archana Santhanam, Herald J. Sherlin, Gifrina Jayaraj, Don K.R | | Journal of Evolution of Medical and Dental Sciences. 2021; 10(32): 2592 | | [Pubmed] | [DOI] | | | 18 |
Multiplexing Liquid Biopsy with Surface-Enhanced Raman Scattering Spectroscopy |
|
| Sara Abalde-Cela, Lei Wu, Alexandra Teixeira, Kevin Oliveira, Lorena Diéguez | | Advanced Optical Materials. 2021; 9(15): 2001171 | | [Pubmed] | [DOI] | | | 19 |
Highly multiplexed immunofluorescence of the human kidney using co-detection by indexing |
|
| Elizabeth K. Neumann, Nathan Heath Patterson, Emilio S. Rivera, Jamie L. Allen, Maya Brewer, Mark P. deCaestecker, Richard M. Caprioli, Agnes B. Fogo, Jeffrey M. Spraggins | | Kidney International. 2021; | | [Pubmed] | [DOI] | | | 20 |
Immune contexture analysis in immuno-oncology: applications and challenges of multiplex fluorescent immunohistochemistry |
|
| Reshma Shakya, Tam Hong Nguyen, Nigel Waterhouse, Rajiv Khanna | | Clinical & Translational Immunology. 2020; 9(10) | | [Pubmed] | [DOI] | | | 21 |
Classification of Cancer Pathology Reports: A Large-Scale Comparative Study |
|
| Stefano Martina, Leonardo Ventura, Paolo Frasconi | | IEEE Journal of Biomedical and Health Informatics. 2020; 24(11): 3085 | | [Pubmed] | [DOI] | | | 22 |
Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers |
|
| Suresh Madheswaran, Neelakshi Mungra, Fleury A.N. Biteghe, Jean De la Croix Ndong, Afolake T. Arowolo, Henry A. Adeola, Dharanidharan Ramamurthy, Krupa Naran, Nonhlanhla P. Khumalo, Stefan Barth | | Anti-Cancer Agents in Medicinal Chemistry. 2020; 21(2): 162 | | [Pubmed] | [DOI] | | | 23 |
Detection of MERS-CoV antigen on formalin-fixed paraffin-embedded nasal tissue of alpacas by immunohistochemistry using human monoclonal antibodies directed against different epitopes of the spike protein |
|
| Ann-Kathrin Haverkamp, Berend J. Bosch, Ingo Spitzbarth, Annika Lehmbecker, Nigeer Te, Albert Bensaid, Joaquim Segalés, Wolfgang Baumgärtner | | Veterinary Immunology and Immunopathology. 2019; 218: 109939 | | [Pubmed] | [DOI] | | | 24 |
The Immune Landscape of Non–Small-Cell Lung Cancer. Utility of Cytologic and Histologic Samples Obtained through Minimally Invasive Pulmonary Procedures |
|
| Jason Beattie, Lonny Yarmus, Momen Wahidi, M. Patricia Rivera, Christopher Gilbert, Fabien Maldonado, Kasia Czarnecka, Angela Argento, Alexander Chen, Felix Herth, Daniel H. Sterman | | American Journal of Respiratory and Critical Care Medicine. 2018; 198(1): 24 | | [Pubmed] | [DOI] | | | 25 |
Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry |
|
| A. Kotzev, M. Kamenova | | Acta Medica Bulgarica. 2017; 44(2): 14 | | [Pubmed] | [DOI] | | | 26 |
Evaluation of a panel of antibodies for the immunohistochemical identification of immune cells in paraffin-embedded lymphoid tissues of new- and old-world camelids |
|
| Ann-Kathrin Uhde,Annika Lehmbecker,Wolfgang Baumgärtner,Ingo Spitzbarth | | Veterinary Immunology and Immunopathology. 2017; 184: 42 | | [Pubmed] | [DOI] | | | 27 |
Application of immunohistochemistry technique in hydrobiological studies |
|
| Hui Zhang,Wen Wen,Jizhou Yan | | Aquaculture and Fisheries. 2017; | | [Pubmed] | [DOI] | | | 28 |
Role of inducible nitric oxide synthase and interleukin-6 expression in estimation of skin burn age and vitality |
|
| Mona M. Abo El-Noor,Fatma M. Elgazzar,Hanan A. Alshenawy | | Journal of Forensic and Legal Medicine. 2017; 52: 148 | | [Pubmed] | [DOI] | | | 29 |
Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis |
|
| Noel Pabalan,Anthicha Kunjantarachot,Chetana Ruangpratheep,Hamdi Jarjanazi,Denise Maria Christofolini,Caio Parente Barbosa,Bianca Bianco | | Gynecologic Oncology. 2017; | | [Pubmed] | [DOI] | | | 30 |
Multiplex Gene Expression Profiling of 16 Target Genes in Neoplastic and Non-Neoplastic Canine Mammary Tissues Using Branched-DNA Assay |
|
| Florenza Lüder Ripoli,Susanne Conradine Hammer,Annika Mohr,Saskia Willenbrock,Marion Hewicker-Trautwein,Bertram Brenig,Hugo Murua Escobar,Ingo Nolte | | International Journal of Molecular Sciences. 2016; 17(9): 1589 | | [Pubmed] | [DOI] | | | 31 |
Porcine epidemic diarrhea virus: An overview of current virological and serological diagnostic methods |
|
| D.G. Diel,S. Lawson,F. Okda,A. Singrey,T. Clement,M.H.V. Fernandes,J. Christopher-Hennings,E.A. Nelson | | Virus Research. 2016; | | [Pubmed] | [DOI] | |
|
 |
|
|
|
